CellSource Co., Ltd. (TYO:4880)
Japan · Delayed Price · Currency is JPY 315.00
+7.00 (2.27%)
Aug 6, 2026, 2:13 PM JST
CellSource Income Statement
Financials in millions JPY. Fiscal year is November - October.
Millions JPY. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2025 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Oct '25 Oct 31, 2025 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 |
| 3,666 | 3,711 | 4,511 | 4,274 | |
Revenue Growth | -19.74% | -17.73% | 5.54% | - |
Cost of Revenue | 1,555 | 1,624 | 1,326 | 1,210 |
Gross Profit | 2,111 | 2,087 | 3,185 | 3,064 |
Selling, General & Admin | 1,835 | 1,920 | 1,136 | 812.85 |
Research & Development | - | - | 72.45 | 87.56 |
Other Operating Expenses | - | - | 733.79 | 575.73 |
Operating Expenses | 1,835 | 1,920 | 1,963 | 1,493 |
Operating Income | 276 | 167 | 1,222 | 1,571 |
Interest Expense | -1 | -1 | -0.38 | -0.01 |
Interest & Investment Income | - | - | 0.01 | 0.01 |
Earnings From Equity Investments | - | - | -3.08 | -3.16 |
Currency Exchange Gain (Loss) | - | - | -8.4 | 20.63 |
Other Non Operating Income (Expenses) | -11 | -1 | -13.58 | 4.67 |
EBT Excluding Unusual Items | 264 | 165 | 1,196 | 1,593 |
Gain (Loss) on Sale of Investments | -13 | -13 | 33 | -9.55 |
Gain (Loss) on Sale of Assets | 1 | 2 | - | - |
Other Unusual Items | -46 | -45 | 10.6 | - |
Pretax Income | 195 | 109 | 1,240 | 1,584 |
Income Tax Expense | 125 | 99 | 316.54 | 565.8 |
Net Income | 70 | 10 | 923.14 | 1,018 |
Net Income to Common | 70 | 10 | 923.14 | 1,018 |
Net Income Growth | -91.39% | -98.92% | -9.30% | - |
Shares Outstanding (Basic) | 20 | 20 | 19 | 19 |
Shares Outstanding (Diluted) | 20 | 20 | 19 | 19 |
Shares Change | 1.47% | 3.29% | 0.25% | - |
EPS (Basic) | 3.53 | 0.50 | 48.88 | 54.54 |
EPS (Diluted) | 3.53 | 0.50 | 47.93 | 52.98 |
EPS Growth | -91.49% | -98.95% | -9.53% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Oct '25 Oct 31, 2025 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 |
Free Cash Flow | 416 | 290 | 498.62 | 752.89 |
Free Cash Flow Per Share | 20.91 | 14.58 | 25.89 | 39.19 |
Dividend Per Share | 5.000 | 5.000 | 5.000 | - |
Dividend Growth | 0% | 0% | - | - |
Gross Margin | 57.58% | 56.24% | 70.61% | 71.70% |
Operating Margin | 7.53% | 4.50% | 27.08% | 36.76% |
Profit Margin | 1.91% | 0.27% | 20.47% | 23.82% |
Free Cash Flow Margin | 11.35% | 7.81% | 11.05% | 17.62% |
EBITDA | 481 | 384 | 1,285 | 1,616 |
EBITDA Margin | 13.12% | 10.35% | 28.50% | 37.82% |
D&A For EBITDA | 205 | 217 | 63.85 | 45.42 |
EBIT | 276 | 167 | 1,222 | 1,571 |
EBIT Margin | 7.53% | 4.50% | 27.08% | 36.76% |
Effective Tax Rate | 64.10% | 90.83% | 25.53% | 35.73% |
Advertising Expenses | - | - | 32.81 | 39.44 |